Skip to main content

Activated Partial Thromboplastin Time Test Market Anticipated for Progressive CAGR Growth During 2020-2027

  The global activated partial thromboplastin time test market forecast will surpass $601.2 million by the end of 2026, at a CAGR of 6.8%, and has been rising from $353.0 million in 2018, according to Activated Partial Thromboplastin Time Test Market Analysis by Research Dive.

Activated Partial Thromboplastin Time Test Market Trends: Rise in the prevalence of cardiovascular diseases coupled with increase in the demand for thromboplastin test instruments the key drivers for the growth of the activated partial thromboplastin time test market Increase in the adoption of thromboplastin test in the point-of-care diagnostic centers and improvements in the healthcare infrastructure are projected to drive the market growth. The improvements in healthcare infrastructure support the accessibility of test instruments and easy available of coagulation testing devices is anticipated to boost the activated partial thromboplastin time (APTT) test market growth. Furthermore, there is a rise in the blood disorders with increasing age of people across the globe; they require regular blood check-up to determine common and intrinsic pathways of blood coagulation. Due to wide usage of APTT test devices, the market is projected to grow in the coming years. Price of the treatment test coupled with dearth of skilled personal to perform APTT test are expected to hinder the growth of the market. Technological improvements in the activated partial thromboplastin time (APTT) testing instruments and key manufacturers concentrating on mergers & acquisitions to minimize the devices cost is anticipated to create ample investment opportunities in the activated partial thromboplastin time test market.

Download FREE Sample Copy of the Report at: https://www.researchdive.com/download-sample/79

Instruments type segment will witness a noteworthy growth during the projected time. The growth is majorly because companies are increasing the R&D activities on diagnostic instruments to improve performance and accuracy of the instruments with low cost. The activated partial thromboplastin time test market for instruments product type is estimated to account for $289.8 million by 2026 at a 7.2% CAGR.

The market for point-of-care testing is projected to experience significant growth; it is anticipated to generate a revenue of $83.6 million by 2026 and is growing at a 7.7% CAGR. This growth is because of an increase in the number of point-of-care testing centers along with an increase in the population with age group above 60. The hospitals segment held the largest activated partial thromboplastin time test market size in 2018; it is estimated to reach $217.6 million by 2026, increasing at a growth rate of 6.5%. This is because of the growing usage of thromboplastin time test devices in the hospitals sector to treat patients for the analysis of hematological.

Asia-Pacific market will witness the highest growth rate of 7.3% CAGR and is expected to register a revenue of $143.1 million by 2026. This growth is attributed to swift progress in healthcare along with people preferring the point of care diagnosis of hospitals. Due to this swift growth, the Asia-Pacific market is predicted to grow during the forecast time. The global activated partial thromboplastin time test market was dominated by Europe, it was registered for majority of the activated partial thromboplastin market share, which was 30.0% in 2018. This growth is owing to the presence of upgraded diagnostic infrastructure in Europe. The market for North America region is expected to generate a revenue of $156.3 million by the end of 2026 with a CAGR of 6.7% during the projected time period.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/79

Top gaining participants in the activated partial thromboplastin time test market are Bio-Rad Laboratories, Inc., ThermoFisher, Abbott, bioMérieux, Inc., Danaher, Hoffmann-La Roche Ltd, Beckman Coulter, Inc., Takara Bio Inc., HORIBA, Ltd., Ortho Clinical Diagnostics and Siemens Healthcare Private Limited. These participants are continuously increasing their efforts to improve the product performance and introducing new technologies to gain the largest market share in the overall activated partial thromboplastin time test industry.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Comments

Post a Comment

Popular posts from this blog

Top Scenario: Wood Pellets Market by Key Vendors, Challenges and Opportunities 2027

   Download FREE Sample       Connect with Analyst Global wood pellets market is going to experience massive growth during the forecast period. Premium grade segment will be the most lucrative. Residential sector will be the most profitable. Industrial sector will garner the highest revenue. North America will witness the highest market growth. Leading players of the market are focusing on developing new strategies such as product launches, merger and acquisition, collaboration to sustain the growth of the global market. Research Dive has published a new report entitled “ Global Wood Pellets Market , by Grade (Premium, Standard, and Utility), Applications (Residential, Commercial, Industrial, and Animal Bedding), End-Users (Industrial, Household, Furniture, and Construction), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2020–2025” The global wood pellets market is expected to...
Post a Comment
Read more

Corona Impact: Is Antiviral Therapy Market will Propel at a Defining Pace 2020

   The rise of COVID-19 pandemic has positively impacted the global antiviral therapy market in 2020. Rising research & development and advances in the production of antiviral drugs is fueling the growth of the market during COVID-19 crisis. A new report by Research Dive deliberates the impact of COVID-19 on the present and future growth of the global antiviral therapy market. This report is formulated by market professionals by considering all the important factors such as regional market conditions, current trends & developments, market drivers and restraints, and size & scope of the market. This report is a valuable source of information and guidance for professionals involved in this market. For More Detail Insights, Download FREE Sample at:   https://www.researchdive.com/download-sample/246 Key Highlights of the Report: The COVID-19 pandemic has imposed a positive impact on the global market for antiviral therapy. As per the report, the global antiviral t...
Post a Comment
Read more

Global GaN RF Devices Industry Is Booming Across the Globe by 2025

The research analysis is a superb account of  macroeconomic and microeconomic factors  influencing the growth of the  “GaN RF Devices Market” . This will help market players to make suitable changes in their approach towards attaining growth and maintaining their position in the industry. The GaN RF Devices Market is  segmented as per sort of product, application, and geography . Each segment is evaluated in an exceptional element so that players can cognizance on high-boom areas of the GaN RF Devices Market and grow their sales boom. Even the competitive panorama is shed light upon  for players to build powerful techniques  and deliver a difficult opposition to other participants inside the GaN RF Devices Market. Summary of Market:   The global GaN RF Devices Market is valued at xx million US$ in 2019 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025 . GaN has superior properties than silicon such a...
Post a Comment
Read more